Recent studies have found that mutant KRAS allelic imbalance is common in human cancers [158,159,160], highlighting that the increased mutant KRAS dosage, rather than a single allelic mutant KRAS alone, plays a more important role in the accentuated KRAS signaling, tumorigenesis, and metastasis [161]. Here, KRAS is linked to cancer.